-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ACTUS-101 in Pompe Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ACTUS-101 in Pompe Disease Drug Details: ACTUS-101 is under development for the treatment of Pompe disease....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CELZ-001 in Type 2 Diabetes
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CELZ-001 in Type 2 DiabetesDrug Details:CELZ-001 is under development for the treatment of type-2 diabetes. The...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VAC-85135 in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.VAC-85135 in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details:VAC-85135 is under development for the treatment of essential...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AB-1003 in Limb-Girdle Muscular Dystrophy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.AB-1003 in Limb-Girdle Muscular DystrophyDrug Details:AB-1003 is under development for the treatment of limb-girdle muscular dystrophy....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Carfostin in Non-ischemic Cardiomyopathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Carfostin in Non-ischemic Cardiomyopathy Drug Details: Carfostin (BNP-CHF) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SKL-27969 in Triple-Negative Breast Cancer (TNBC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SKL-27969 in Triple-Negative Breast Cancer (TNBC) Drug Details:SKL-27969 is under development for the treatment of advanced...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drug Details:...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Carfostin in Congestive Heart Failure (Heart Failure)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Carfostin in Congestive Heart Failure (Heart Failure) Drug Details: Carfostin (BNP-CHF) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AB-1005 in Parkinson’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AB-1005 in Parkinson's Disease Drug Details: Gene therapy is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TQB-2618 in Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TQB-2618 in Melanoma Drug Details: TQB-2618 is under development for the treatment of advanced solid...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.